Bank of New York Mellon
CRTX

Bank of New York Mellon’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Bank of New York Mellon’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-40,188
Closed -$382K – 4290
2013
Q4 		$382K Buy
40,188
+15,427
+62% +$146K ﹤0.01% 3672
2013
Q3 		$234K Sell
24,761
-323
-1% -$2.91K ﹤0.01% 3756
2013
Q2 		$201K Buy
+25,084
New +$211K ﹤0.01% 3776

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Bank of New York Mellon's CRTX Position: Q1 2014 in Review

Bank of New York Mellon sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 40,188 shares — an estimated $382K sold.

Bank of New York Mellon first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $382K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Bank of New York Mellon reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Bank of New York Mellon sold 40,188 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $382K.
  • Bank of New York Mellon first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • Bank of New York Mellon's CORNERSTONE THERAPEUTICS INC position peaked at $382K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Bank of New York Mellon's 13F filing for Q1 2014, filed 14 May 2014.